Inflammasome activation and metabolic disease progression
- 1 December 2014
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 25 (6) , 699-706
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB SignalingImmunity, 2012
- Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatmentEMBO Molecular Medicine, 2011
- Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease?Genes & Nutrition, 2011
- NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for ColitisCell, 2011
- Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutationArthritis & Rheumatism, 2011
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin SensitivityCell Metabolism, 2010
- The InflammasomesCell, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Hypothalamic IKKβ/NF-κB and ER Stress Link Overnutrition to Energy Imbalance and ObesityCell, 2008
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut MicrobiomeCell Host & Microbe, 2008